RaQualia Pharma, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3967150008
JPY
795.00
35 (4.61%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,979.96
3,107.57
1,901.20
2,918.04
2,776.23
1,107.30
1,702.97
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,979.96
3,107.57
1,901.20
2,918.04
2,776.23
1,107.30
1,702.97
Raw Material Cost
1,004.79
1,024.57
420.62
379.32
462.23
262.27
398.96
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
61.05
184.11
6.68
6.00
1.45
0.44
0.00
Selling and Distribution Expenses
891.59
780.68
613.99
565.50
614.91
517.82
587.12
Other Expenses
153.88
133.16
119.73
110.10
98.98
81.29
73.28
Total Expenditure (Excl Depreciation)
3,496.24
3,320.96
2,238.57
2,051.80
2,068.37
1,593.38
1,718.92
Operating Profit (PBDIT) excl Other Income
483.7
-213.4
-337.40000000000003
866.2
707.9000000000001
-486.1
-15.9
Other Income
-10.92
63.28
71.67
55.72
184.20
-39.69
39.09
Operating Profit (PBDIT)
960.96
251.55
-90.14
1,069.68
1,033.62
-401.51
163.19
Interest
61.05
184.11
6.68
6.00
1.45
0.44
0.00
Exceptional Items
26.20
-23.51
-21.66
-64.95
-10.03
-1.73
4.17
Gross Profit (PBDT)
2,975.16
2,083.01
1,480.59
2,538.72
2,314.00
845.03
1,304.02
Depreciation
488.16
401.65
175.56
147.73
141.56
124.25
140.05
Profit Before Tax
437.95
-357.73
-294.05
851.01
880.58
-527.94
27.31
Tax
164.83
137.30
29.61
127.62
124.79
79.04
21.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
273.12
-495.03
-323.66
723.39
755.79
-606.99
5.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
273.12
-495.03
-323.66
723.39
755.79
-606.99
5.34
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
273.12
-495.03
-323.66
723.39
755.79
-606.99
5.34
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,896.26
5,570.51
6,120.44
5,496.98
4,788.00
4,011.13
4,620.65
Earnings per share (EPS)
11.36
-22.87
-14.98
34.47
36.04
-28.97
0.26
Diluted Earnings per share
11.36
-22.87
-14.98
34.47
36.04
-28.97
0.26
Operating Profit Margin (Excl OI)
12.15%
-6.87%
-17.74%
29.69%
25.5%
-43.9%
-0.94%
Gross Profit Margin
23.27%
1.41%
-6.23%
34.23%
36.82%
-36.46%
9.83%
PAT Margin
6.86%
-15.93%
-17.02%
24.79%
27.22%
-54.82%
0.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 28.07% vs 63.45% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 155.17% vs -52.92% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 416.14% vs 216.38% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -66.81% vs 2,647.76% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of RaQualia Pharma, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
3,979.96
0.00
3,979.96
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,979.96
0.00
3,979.96
Raw Material Cost
1,004.79
0.00
1,004.79
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
61.05
0.00
61.05
Selling and Distribution Expenses
891.59
193.56
698.03
360.63%
Other Expenses
153.88
82.00
71.88
87.66%
Total Expenditure (Excl Depreciation)
3,496.24
1,013.56
2,482.68
244.95%
Operating Profit (PBDIT) excl Other Income
483.72
-1,013.56
1,497.28
147.72%
Other Income
-10.92
-47.10
36.18
76.82%
Operating Profit (PBDIT)
960.96
-1,156.67
2,117.63
183.08%
Interest
61.05
0.00
61.05
Exceptional Items
26.20
0.00
26.20
Gross Profit (PBDT)
2,975.16
0.00
2,975.16
Depreciation
488.16
0.00
488.16
Profit Before Tax
437.95
-1,156.67
1,594.62
137.86%
Tax
164.83
1.25
163.58
13,086.40%
Provisions and contingencies
0
0
0.00
Profit After Tax
273.12
-1,157.92
1,431.04
123.59%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
273.12
-1,157.92
1,431.04
123.59%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
273.12
-1,157.92
1,431.04
123.59%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,896.26
2,943.89
3,952.37
134.26%
Earnings per share (EPS)
11.36
-61.14
72.50
118.58%
Diluted Earnings per share
11.36
-61.14
72.50
118.58%
Operating Profit Margin (Excl OI)
12.15%
0.00%
0.00
12.15%
Gross Profit Margin
23.27%
0.00%
0.00
23.27%
PAT Margin
6.86%
0.00%
0.00
6.86%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 398.00 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 28.07% vs 63.45% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 27.31 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 155.17% vs -52.92% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 97.19 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 416.14% vs 216.38% in Dec 2024

Annual - Interest
Interest 6.11 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -66.81% vs 2,647.76% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.15%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024